WBP1LP4

Q-omics provides the consensus-scored WBP1LP4 profile across patient tissues and cancer cell-line models. WBP1LP4 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in UVM. Additionally, WBP1LP4 RNA expression shows 229 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight UVM, and STAD as cancer lineages where WBP1LP4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes WBP1LP4 survival associations across molecular data types. WBP1LP4 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

WBP1LP4 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	UVM (54)	view →

This table ranks reproducible WBP1LP4 RNA expression–survival associations across cancer types. High WBP1LP4 expression shows unfavorable associations in UVM and GBM. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for WBP1LP4 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.071	0.746	<.001	54	view →
GBM	OS	Tertile	All	0.024	0.416	<.001	18	view →

Pink = unfavorable, green = favorable. all 2 lineages →

WBP1LP4-UVM (DFS)

Explore this curve interactively →